|
|
¿¬±¸Á¤º¸ (Information) |
|
| | ±¹¿Ü¿¬±¸Á¤º¸ (Foreign information) | |
|
|
|
|
|
|
|
|
|
|
Yesterday : 103
|
Today : 66
|
Max : 758
|
Total : 307,314
|
|
|
|
|
|
|
|
|
|
|
|
±¹¿Ü¿¬±¸Á¤º¸ (Foreign information) |
¢Æ Home | > | | ¿¬±¸Á¤º¸ (Information) | > | ±¹¿Ü¿¬±¸Á¤º¸ (Foreign information) |
|
|
|
|
|
|
Pinnothin¢â suppresses appetite in overweight women |
|
|
±Û¾´ÀÌ : °ü¸®ÀÚ
³¯Â¥ : 08-06-09 17:36
Á¶È¸ : 16121
|
|
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WB2-4P5SCRM¡¦ (8004) |
|
Pinnothin¢â suppresses appetite in overweight women. <Appetite 49(1):330 July 2007>
Controlling food intake by suppressing appetite can potentially be one of the principal approaches to preventing weight gain and obesity. A major gut hormone involved in appetite control is cholecystokinin (CCK), where previous experiments showed that polyunsaturated fatty acids (PUFAs) derived from Korean pine nuts (Pinus koraiensis) PinnoThin¢â induces high amounts of CCK release by STC-1 enteroendocrine cells. This study investigates the effects of PinnoThin¢â on appetite sensations and appetite-regulating hormones in humans. A randomized, cross-over, placebo-controlled, double-blind study was performed with 18 overweight post-menopausal women (BMI=25–30 kg/m2) receiving capsules with 3 g PinnoThin¢â or olive oil (placebo) with a light breakfast. At 0, 30, 60, 90, 120, 180 and 240 min following supplementation blood samples were taken for analyses of appetite suppressing hormones CCK and glucagon-like peptide-1 (GLP-1). Appetite sensations were evaluated by using visual analogue scales. PinnoThin¢â significantly induced CCK after 30 min and GLP-1 after 60 min relative to placebo. Over a period of 4 h the total amount of plasma CCK and GLP-1 in response to PinnoThin¢â was 60% (P<0.0001) and 25% (P<0.05) higher than in response to placebo, respectively. PinnoThin¢â affected appetite sensations during the 4 hours after intake. Especially, at 30 minutes the ¡°desire to eat¡± and the ¡°prospective food intake¡± scores were, 29% and 36% lower relative to placebo, respectively. PinnoThin¢â significantly increased CCK and GLP-1 levels and affected appetite sensations, suggesting that PinnoThin¢â may affect food intake. Further clinical work aimed at understanding the role of PinnoThin¢â and satiety will be discussed.
|
|
|
|
|
|